| Model Number |
SOLOFUSE1 |
| Medical Device Problem Code |
Intermittent Capture (1080)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
08/20/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
During a follow-up interview with the user, it was determined that loss of capture occurred during the procedure.Review of the procedural imaging identified that the fusion wire was positioned on top of the mitral valve apparatus where loss of contact is a known risk during valve deployment when balloon inflation shifts the relationship of the conducting part of the lead wire to the myocardium and leads to loss of contact and resultant loss of capture.The epg was evaluated and found to be within specification for all requirements and testing did not identify any pacing or sensing issues.A review of the epg logs did not identify any pacing or sensing issues.A review of the production records did not identify an issue with the epg or fusion components.Based on the information obtained from the customer and review of the imaging, the valve embolization appears to be due to the position of the fusion wire, which resulted in loss of capture.
|
| |
|
Event or Problem Description
|
|
Customer reports that the valve embolized while using solopace fusion.Valve that embolized required a stent to secure.Patient outcome was good.
|
| |
|
Search Alerts/Recalls
|